Experimental pill targets Hard-to-Treat cancers in groundbreaking trial
Disease control
Recruiting now
This early-stage trial is testing a new oral medication called NST-628 for adults with advanced solid tumors that have specific genetic changes in a key cancer growth pathway. The study aims to find a safe and effective dose and see if the drug can shrink tumors in patients who h…
Phase: PHASE1 • Sponsor: Nested Therapeutics, Inc • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC